Innoviva (INVA) Goodwill & Intangibles (2013 - 2026)
Innoviva (INVA) posted Goodwill & Intangibles of $193.5 million for Q1 2026, down 3.28% on a QoQ basis from $200.1 million in Q4 2025, and down 30.79% year-over-year from $279.6 million in Q1 2025.
Innoviva (INVA) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Innoviva's Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $193.5 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 30.79% year-over-year to $193.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.5 million (down 30.79% YoY) and the FY2025 annual result came in at $200.1 million, down 28.45% from the prior year.
- Goodwill & Intangibles was $193.5 million for Q1 2026 at Innoviva, down from $200.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $279.6 million in Q4 2024 and bottomed at $105.0 million in Q2 2022.
- A 5-year average of $229.4 million and a median of $248.2 million in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles surged 125.71% — and 2026, when it tumbled 30.79%.
- Innoviva's Goodwill & Intangibles stood at $262.2 million in 2022, then declined by 5.33% to $248.2 million in 2023, then advanced by 12.64% to $279.6 million in 2024, then fell by 28.45% to $200.1 million in 2025, then fell by 3.28% to $193.5 million in 2026.
- Business Quant data shows INVA's Goodwill & Intangibles at $193.5 million in Q1 2026, $200.1 million in Q4 2025, and $206.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Innoviva | 1.61 Bn | 1.01 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.50 Mn |
| Dec 31, 2025 | 200.06 Mn |
| Sep 30, 2025 | 206.69 Mn |
| Jun 30, 2025 | 213.31 Mn |
| Mar 31, 2025 | 279.60 Mn |
| Dec 31, 2024 | 279.60 Mn |
| Sep 30, 2024 | 275.60 Mn |
| Jun 30, 2024 | 275.60 Mn |
| Mar 31, 2024 | 275.61 Mn |
| Dec 31, 2023 | 248.24 Mn |
| Sep 30, 2023 | 238.05 Mn |
| Jun 30, 2023 | 230.26 Mn |
| Mar 31, 2023 | 249.51 Mn |
| Dec 31, 2022 | 262.20 Mn |
| Sep 30, 2022 | 256.19 Mn |
| Jun 30, 2022 | 105.00 Mn |
| Mar 31, 2022 | 110.54 Mn |
| Sep 30, 2014 | 211.65 Mn |
| Jun 30, 2014 | 194.88 Mn |
| Mar 31, 2014 | 137.48 Mn |